A bipartisan group of lawmakers from both houses of Congress reintroduced on Thursday the Marijuana Data Collection Act, a bill that would require the federal government to study the effects of legal cannabis. The measure, which was previously introduced by a bipartisan group of lawmakers in 2018 and again in 2019, is sponsored by Democratic Sen. Bob Menendez of New Jersey, Republican Sen. Rand Paul of Kentucky, Democratic Rep. Sylvia Garcia of Texas, and Rep. Don Young, a Republican from Alaska.
“As more and more states legalize and regulate marijuana, we must take a thorough examination at how different laws and policies in different states have been implemented, what works, what doesn’t, and what can be replicated elsewhere,” Menendez said in a statement on the legislation. “It’s important to understand how communities and people are ultimately impacted by marijuana legalization and its effect on local economies, public health, criminal justice, employment, and our nation’s battle with opioid and other drug addiction. Having this data at our fingertips and making it available to the public will help drive public policy decisions and dispel any misconceptions about marijuana legalization.”
The bill would require the Secretary of Health and Human Services, the Attorney General, the Secretary of Labor, and relevant state health agencies to enter a ten-year arrangement with the National Academy of Sciences to conduct a study on the effects of legalized state marijuana programs every two years. The research would evaluate the effects of legal recreational and medical cannabis programs on state economies, public health, criminal justice, and employment.
“Congress and the American people need reliable facts on the impact of states’ legal marijuana programs. We need independent data on how these programs impact state budgets, the public health, and employment,” said Garcia. “This is especially important amid the pandemic, that’s been filled for many with isolation, depression, and financial stress that has led to an alarming rise in opioid deaths—especially among communities of color.”
Marijuana Data Collection Act Puts Medical Marijuana Under The Microscope